CNS Co.,Ltd carries a market capitalization of 4.97B, placing it among publicly traded companies globally. Its enterprise value stands at 1.35B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 4.97B |
| Enterprise Value | 1.35B |
CNS Co.,Ltd currently has 2.91M shares outstanding.
| Shares Outstanding | 2.91M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
CNS Co.,Ltd trades at a trailing price-to-earnings ratio of 10.65. The price-to-sales ratio is 0.74, and the price-to-book ratio stands at 1.52.
| PE Ratio | 10.65 |
| PS Ratio | 0.74 |
| PB Ratio | 1.52 |
| P/TBV Ratio | 1.36 |
| P/FCF Ratio | N/A |
| P/OCF Ratio | N/A |
On an enterprise value basis, CNS Co.,Ltd trades at an EV/EBITDA multiple of 2.18 and an EV/FCF ratio of 6,537.64. The EV/Sales ratio of 0.20 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 2.18 provides insight into valuation relative to core operating earnings.
| EV / Sales | 0.20 |
| EV / EBITDA | 2.18 |
| EV / EBIT | 2.18 |
| EV / FCF | 6,537.64 |
CNS Co.,Ltd maintains a current ratio of 5.21, meaning it holds 5.2x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 0.29, indicating conservative leverage, while an interest coverage ratio of 2,175.35 demonstrates limited ability to service its debt obligations.
| Current Ratio | 5.21 |
| Quick Ratio | 4.28 |
| Debt / Equity | 0.29 |
| Debt / EBITDA | 0.02 |
| Interest Coverage | 2,175.35 |
CNS Co.,Ltd posts a return on equity of 15.02 and a return on invested capital of 12.20.
| Return on Equity (ROE) | 15.02 |
| Return on Assets (ROA) | 9.73 |
| Return on Invested Capital (ROIC) | 12.20 |
| Return on Capital Employed (ROCE) | 14.97 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 519.27 |
Over the trailing twelve months, CNS Co.,Ltd has paid 175.16M in income taxes, reflecting an effective tax rate of 27.52.
| Income Tax | 175.16M |
| Effective Tax Rate | 27.52 |
CNS Co.,Ltd's stock has gained approximately 13.77246% over the past 52 weeks. The 50-day moving average sits at 1,696.54, while the 200-day moving average is 1,691.71.
| Beta (5Y) | N/A |
| 52-Week Price Change | 13.77246% |
| 50-Day Moving Average | 1,696.54 |
| 200-Day Moving Average | 1,691.71 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, CNS Co.,Ltd generated 6.66B in revenue and converted that into 461.33M in net income, yielding earnings per share of 158.76. EBITDA reached 619.97M, while operating income came in at 619.97M.
| Revenue | 6.66B |
| Gross Profit | 1.64B |
| Operating Income | 619.97M |
| Pretax Income | 636.49M |
| Net Income | 461.33M |
| EBITDA | 619.97M |
| EBIT | 619.97M |
| Earnings Per Share (EPS) | 158.76 |
CNS Co.,Ltd holds 3.57B in cash and equivalents against 10.65M in total debt, resulting in a net debt position of -3.57B. Total book value stands at 3.24B, with working capital of 3.51B providing operational flexibility.
| Cash & Cash Equivalents | 3.57B |
| Total Debt | 10.65M |
| Net Debt | -3.57B |
| Equity (Book Value) | 3.24B |
| Book Value Per Share | 1,113.98 |
| Working Capital | 3.51B |
CNS Co.,Ltd operates with a gross margin of 24.63, reflecting its pricing power and cost economics. The operating margin of 9.31 and net profit margin of 6.93 provide insight into operational efficiency.
| Gross Margin | 24.63 |
| Operating Margin | 9.31 |
| Pretax Margin | 9.56 |
| Profit Margin | 6.93 |
| EBITDA Margin | 9.31 |
CNS Co.,Ltd posts an Altman Z-Score of 5.77, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 5.77 |